Clinical Trials for Prostate Cancer

Find clinical trials for prostate cancer. Discover research opportunities and treatment options in your area.

786 Active Trials Found

Showing 786 trials on this page

Page 1 of 40

A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.

NCT ID: NCT05938270

This clinical trial, called ASCERTAIN, is investigating the effects of two medications, Saruparib (AZD5305) and Darolutamide, on men who have recently been diagnosed with prostate cancer. The goal ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States, Barcelona, Spain +17 more

Collection of Blood From Patients With Cancer

NCT ID: NCT00034216

This clinical trial is studying how certain types of cells in the blood that can weaken the immune system (called suppressor cells) change before and after chemotherapy in patients with different t...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

NCT ID: NCT05588128

This clinical trial is studying a new imaging test called 18F-DCFPyL PET/CT scans to see if it can help detect areas of prostate cancer in men whose cancer has returned after initial treatment. Pro...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

NCT ID: NCT05616650

This clinical trial is studying a new treatment called Stereotactic Body Radiation Therapy (SBRT) for men with a single tumor in their prostate, which is a common type of prostate cancer. The goal ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy

NCT ID: NCT01834001

This clinical trial is investigating how well radiation therapy works for treating prostate cancer and aims to understand why some tumors do not respond as effectively to this treatment. By using a...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

NCT ID: NCT01441089

This clinical trial is studying how certain genes may affect the way people with cancer respond to treatment. Researchers believe that some genes can influence the side effects of treatment and how...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

Evaluating Tolerability of ePUHRT With Brachytherapy Boost

NCT ID: NCT06817668

This clinical trial is studying a new way to treat prostate cancer by combining two types of radiation therapy: Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT), which is a typ...

Recruiting

Phase: NA Type: interventional Locations: Indianapolis, Indiana, United States

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

NCT ID: NCT01492972

This clinical trial is examining two different treatment approaches for men with intermediate risk prostate cancer. Researchers want to find out how effective and safe hypofractionated proton beam ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Warrenville, Illinois, United States, Scottsdale, Arizona, United States +2 more

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

NCT ID: NCT04692675

This clinical trial is studying how a special type of imaging called multiparametric magnetic resonance imaging (mpMRI) can help doctors monitor men with low to intermediate risk prostate cancer wh...

Recruiting

Phase: NA Type: interventional Locations: Bethesda, Maryland, United States

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

NCT ID: NCT06925737

This clinical trial is studying a new treatment called ifinatamab deruxtecan (I-DXd) for men with metastatic castration-resistant prostate cancer (mCRPC), a type of cancer that has spread and is no...

Recruiting

Phase: PHASE3 Type: interventional Locations: Melbourne, Victoria, Australia, Billings, Montana, United States +22 more

Improving Health Literacy in African-American Prostate Cancer Patients

NCT ID: NCT03322891

This study is looking at how African-American men with early-stage prostate cancer understand conversations about their treatment options. The researchers want to see if giving patients an easy-to-...

Recruiting

Phase: NA Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States +2 more

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT05919264

This clinical trial, called FOG-001, is investigating a new treatment for people with advanced or metastatic solid tumors, which are types of cancer that have spread beyond their original site. The...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States +9 more

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

NCT ID: NCT06759701

This clinical trial is exploring how effective a weight loss program using a medication called tirzepatide can be for men with diabetes who also have intermediate-risk prostate cancer. The study ai...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Houston, Texas, United States

A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults

NCT ID: NCT07149831

This clinical trial is studying a new imaging agent called Flotufolastat F-18 Injection, which helps doctors take detailed pictures of the prostate using a special type of scan called a PET scan. T...

Recruiting

Phase: PHASE1 Type: interventional

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

NCT ID: NCT07146113

This clinical trial is studying how men with a specific type of prostate cancer, called de novo metastatic hormone-sensitive prostate cancer, are being treated in Russia. It also looks at certain b...

Recruiting

Type: observational

Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

NCT ID: NCT07052578

This clinical trial is studying how doctors in Russia currently treat men with a specific type of aggressive prostate cancer that has spread to other parts of the body but still responds to hormone...

Recruiting

Type: observational Locations: Moscow, Russian Federation, Ekaterinburg, Russian Federation +11 more

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

NCT ID: NCT06395753

This clinical trial is studying a new treatment called Debio 4228 for men with advanced prostate cancer that has spread to other parts of the body. The main goal of the trial is to understand how t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Valencia, Spain, Clermont Ferrand, France +32 more

Non-Invasive Biomarkers in Prostate Cancer Disease Management

NCT ID: NCT06144619

This clinical trial is looking at how certain non-invasive tests can help manage prostate cancer. Specifically, it aims to gather information from men who have been diagnosed with low to high-risk ...

Recruiting

Type: observational Locations: Tampa, Florida, United States

Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

NCT ID: NCT06235151

This clinical trial is exploring the use of a new imaging technique called copper Cu 64 PSMA I&T PET/CT scanning to help doctors see and evaluate prostate cancer in men who have recently been diagn...

Recruiting

Phase: PHASE3 Type: interventional Locations: Orange, California, United States, New York, New York, United States +38 more

Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)

NCT ID: NCT07145437

This clinical trial is studying a new way to predict which men with localized prostate cancer might experience long-term side effects from a precise type of radiation treatment called stereotactic ...

Not yet recruiting

Phase: NA Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Heart Failure View clinical trials →

Search All Trials Browse All Conditions